Optimizing expression of active Botulinum Toxin type E

Optimizing expression of active Botulinum Toxin type E

Nucleic acid molecules that comprise modified open reading frames providing increased expression of the encoded active BoNT/E in a heterologous cell, expression constructs and cells comprising such nucleic acid molecules and methods useful for expressing the encoding active BoNT/E from such nucleic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Steward, Lance E, Gilmore, Marcella A, Fernandez-Salas, Ester G, Li, Shengwen, Miller, Ronald G, Aoki, Kei Roger
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Steward, Lance E
Gilmore, Marcella A
Fernandez-Salas, Ester G
Li, Shengwen
Miller, Ronald G
Aoki, Kei Roger
description Nucleic acid molecules that comprise modified open reading frames providing increased expression of the encoded active BoNT/E in a heterologous cell, expression constructs and cells comprising such nucleic acid molecules and methods useful for expressing the encoding active BoNT/E from such nucleic acid molecules, expression constructs and cells.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07825233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07825233</sourcerecordid><originalsourceid>FETCH-uspatents_grants_078252333</originalsourceid><addsrcrecordid>eNrjZDDzLyjJzM2sysxLV0itKChKLS7OzM9TyE9TSEwuySxLVXDKLynNycwrzVUIya_IzFMoqSxIVXDlYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDcwsjUyNjYmAglAImWLoo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Optimizing expression of active Botulinum Toxin type E</title><source>USPTO Issued Patents</source><creator>Steward, Lance E ; Gilmore, Marcella A ; Fernandez-Salas, Ester G ; Li, Shengwen ; Miller, Ronald G ; Aoki, Kei Roger</creator><creatorcontrib>Steward, Lance E ; Gilmore, Marcella A ; Fernandez-Salas, Ester G ; Li, Shengwen ; Miller, Ronald G ; Aoki, Kei Roger ; Allergan, Inc</creatorcontrib><description>Nucleic acid molecules that comprise modified open reading frames providing increased expression of the encoded active BoNT/E in a heterologous cell, expression constructs and cells comprising such nucleic acid molecules and methods useful for expressing the encoding active BoNT/E from such nucleic acid molecules, expression constructs and cells.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7825233$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7825233$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Steward, Lance E</creatorcontrib><creatorcontrib>Gilmore, Marcella A</creatorcontrib><creatorcontrib>Fernandez-Salas, Ester G</creatorcontrib><creatorcontrib>Li, Shengwen</creatorcontrib><creatorcontrib>Miller, Ronald G</creatorcontrib><creatorcontrib>Aoki, Kei Roger</creatorcontrib><creatorcontrib>Allergan, Inc</creatorcontrib><title>Optimizing expression of active Botulinum Toxin type E</title><description>Nucleic acid molecules that comprise modified open reading frames providing increased expression of the encoded active BoNT/E in a heterologous cell, expression constructs and cells comprising such nucleic acid molecules and methods useful for expressing the encoding active BoNT/E from such nucleic acid molecules, expression constructs and cells.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDDzLyjJzM2sysxLV0itKChKLS7OzM9TyE9TSEwuySxLVXDKLynNycwrzVUIya_IzFMoqSxIVXDlYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDcwsjUyNjYmAglAImWLoo</recordid><startdate>20101102</startdate><enddate>20101102</enddate><creator>Steward, Lance E</creator><creator>Gilmore, Marcella A</creator><creator>Fernandez-Salas, Ester G</creator><creator>Li, Shengwen</creator><creator>Miller, Ronald G</creator><creator>Aoki, Kei Roger</creator><scope>EFH</scope></search><sort><creationdate>20101102</creationdate><title>Optimizing expression of active Botulinum Toxin type E</title><author>Steward, Lance E ; Gilmore, Marcella A ; Fernandez-Salas, Ester G ; Li, Shengwen ; Miller, Ronald G ; Aoki, Kei Roger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_078252333</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Steward, Lance E</creatorcontrib><creatorcontrib>Gilmore, Marcella A</creatorcontrib><creatorcontrib>Fernandez-Salas, Ester G</creatorcontrib><creatorcontrib>Li, Shengwen</creatorcontrib><creatorcontrib>Miller, Ronald G</creatorcontrib><creatorcontrib>Aoki, Kei Roger</creatorcontrib><creatorcontrib>Allergan, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Steward, Lance E</au><au>Gilmore, Marcella A</au><au>Fernandez-Salas, Ester G</au><au>Li, Shengwen</au><au>Miller, Ronald G</au><au>Aoki, Kei Roger</au><aucorp>Allergan, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Optimizing expression of active Botulinum Toxin type E</title><date>2010-11-02</date><risdate>2010</risdate><abstract>Nucleic acid molecules that comprise modified open reading frames providing increased expression of the encoded active BoNT/E in a heterologous cell, expression constructs and cells comprising such nucleic acid molecules and methods useful for expressing the encoding active BoNT/E from such nucleic acid molecules, expression constructs and cells.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07825233
source USPTO Issued Patents
title Optimizing expression of active Botulinum Toxin type E
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A15%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Steward,%20Lance%20E&rft.aucorp=Allergan,%20Inc&rft.date=2010-11-02&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07825233%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true